Revance Therapeutics Inc (RVNC)
3.08
+0.01
(+0.33%)
USD |
NASDAQ |
Dec 20, 16:00
3.05
-0.03
(-0.97%)
After-Hours: 20:00
Revance Therapeutics Shareholders Equity (Quarterly): -163.03M for Sept. 30, 2024
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Recursion Pharmaceuticals Inc | 524.56M |
| Regeneron Pharmaceuticals Inc | 29.33B |
| Ligand Pharmaceuticals Inc | 841.18M |
| MEI Pharma Inc | 24.88M |
| Cellectar Biosciences Inc | 15.16M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 461.56M |
| Total Liabilities (Quarterly) | 624.59M |
| Debt to Equity Ratio | -2.645 |
| Current Ratio | 4.119 |
| Net Debt Paydown Yield | -1.87% |